DBA02

Organization name

Dianosic - SAS

SRN

FR-MF-000003648

Manufacturer status

Active

6 warnings recorded — scroll inside the panel to see all entries.

• CW009

  EUDAMED did not publish a description for this code.
• CW001

  EUDAMED did not publish a description for this code.
• CW007

  EUDAMED did not publish a description for this code.
• CW032

  EUDAMED did not publish a description for this code.
• CW999

  Do not use CAVI-T in the non-adult population < 18 years.
• CW999

  CAVI-T® use is contraindicated in the following situations: • severe cranio-facial trauma and / or polytrauma • suspicion of benign or malignant tumor of the nasal fossa (e.g. nasopharyngeal fibroma) • uncontrolled airway • hemodynamic instability • severe nasal septal deviation

Primary placement in France; available across 8 countries total.

Trade name

not provided

UDI-DI code

03665870000047

Basic UDI-DI

366587CAVITDX

Reference / catalog number

DBA02

Issuing entity

GS1

Risk category

Class IIa

Applicable legislation

MDR [Regulation (EU) 2017/745 on medical devices]

Status

On the market

Quantity

1

Additional product description

DBA02 Primary pachaging

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

No clinical sizes registered for this device.

• Q030201EPISTAXIS CATHETERS

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification